Yifeng Pharmacy Chain (603939) Q3 2026 earnings summary

Executive summary

• Q3 revenue increased 9.73% YoY to RMB6.106bn; attributable net profit rose 12.89% to RMB392.5m, or 18.90% on an adjusted basis.

• 9M revenue grew 5.49% to RMB18.236bn; attributable net profit increased 10.36% to RMB1.362bn, or 13.54% adjusted.

Financial highlights

• Q3 total profit rose 15.33% YoY to RMB584.0m; 9M total profit increased 14.45% to RMB2.026bn.

• Q3 adjusted net profit was RMB371.5m versus RMB312.4m in the adjusted prior-year period; 9M adjusted net profit was RMB1.288bn versus RMB1.134bn.

• 9M operating cash flow increased 22.83% YoY to RMB2.785bn.

Segment performance

• 9M: 369 stores opened, 11 acquired, 137 closed and 378 franchise stores added; period-end network reached 15,452 locations, net up 621 from year-end.

• Q3: 158 stores opened, 60 closed and 115 franchise stores added; period-end network comprised 10,761 directly operated stores and 4,691 franchise stores.